IMMUCELL CORP /DE/
For the period ended Dec 31, 2024. Filed Mar 28, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 28, 2025
ICCC$10.26+0.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Balance Sheets as of December 31, 2024 and 2023
BALANCE SHEETS
| As of December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| ASSETS | ||
| CURRENT ASSETS: | ||
| Cash and cash equivalents | $3,758,232 | $978,741 |
| Trade accounts receivable | 3,771,133 | 2,185,383 |
| Inventory | 7,112,623 | 7,811,841 |
| Prepaid expenses and other current assets | 400,762 | 493,885 |
| Total current assets | 15,042,750 | 11,469,850 |
| Property, plant and equipment, net | 25,349,019 | 27,575,683 |
| Operating lease right-of-use asset | 4,560,679 | 4,571,149 |
| Goodwill | 95,557 | 95,557 |
| Intangible assets, net | 19,104 | 38,208 |
| Other assets | 33,368 | 57,655 |
| TOTAL ASSETS | $45,100,477 | $43,808,102 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| CURRENT LIABILITIES: | ||
| Current portion of debt obligations | $1,497,619 | $1,428,807 |
| Current portion of operating lease liability | 432,072 | 644,276 |
| Accounts payable and accrued expenses | 2,482,522 | 2,124,337 |
| Total current liabilities | 4,412,213 | 4,197,420 |
| LONG-TERM LIABILITIES: | ||
| Debt obligations, net of current portion | 9,040,975 | 10,540,496 |
| Operating lease liability, net of current portion | 4,129,102 | 4,077,109 |
| Total long-term liabilities | 13,170,077 | 14,617,605 |
| TOTAL LIABILITIES | 17,582,290 | 18,815,025 |
| CONTINGENT LIABILITIES AND COMMITMENTS (See Note 10) | ||
| STOCKHOLDERS’ EQUITY: | ||
| Common stock, $0.10 par value per share, with 15,000,000 shares authorized and 9,042,392 and 7,814,165 shares issued and 8,979,091 and 7,750,864 shares outstanding as of December 31, 2024 and 2023, respectively | 904,240 | 781,417 |
| Additional paid-in capital | 40,916,155 | 36,357,239 |
| Accumulated deficit | (14,163,726) | (12,007,097) |
| Treasury stock, at cost, 63,301 shares as of both December 31, 2024 and 2023 | (138,482) | (138,482) |
| Total stockholders’ equity | 27,518,187 | 24,993,077 |
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $45,100,477 | $43,808,102 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.